Sucrose dilaurate
| Product Name | Sucrose dilaurate |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-51135 |
| CAS No. | 25915-57-5 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 164.16 g/mol |
| Mol. For. | C6H12O5 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
GD3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD1bCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | D-galactosyl-α-1,1' N-palmitoyl-D-erythro-sphingosine | GM1bCer d18:1/20:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | FucGM1Cer d20:1/16:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | LS-tetrasaccharide c | Glucobrassicine | GT2 | NeuAca2, 6Galb1, 4GlcNAc | GT2Cer d20:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | D-fructofuranose | GD1bsph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | nLc4Cer d18:1/18:0-Biotin (Galb1,4GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | ALewis B (ALe b ) | FucGM1Cer d18:1/16:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d20:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GD2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | GT3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Trifucosyllacto-N-hexaose | GM1aCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | SSEA-4 d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GlcNAcb1, 3(Neu5Aca2, 6)Galb1, 4GlcNAc | Ac4 GalNAz | iGB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GT2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1aCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2sph d18:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GT3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM1aCer d18:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | iGB3Cer d18:1/18:0-Biotin (Gala1,3Galb1,4GlcbCeramide-Biotin) | GD1aCer d20:1/20:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD1aCer d18:1/20:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1asph d18:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1 | GT3Cer d18:1/8:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Glucobrassicanapin potassium salt | GD1bCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d20:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d18:1/24:1 (Neu5Aca2,3Galb1,4GlcbCeramide) | Glucoerucin potassium salt | GM1aCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Galc d18:1/18:1（GalaCeramide） | GT1csph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GlcNAcb1, 3Galb1, 4GlcNAc | GD1aCer d18:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Zymosan | Sialyl-iGB5Cer d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GD1asph d20:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Carrageenan | GT2Cer d20:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GalNAcb1, 3Gal | Blood type tetrasaccharide A Type VI | LacNAc PEG-NH2 | GlcNAcb1, 3Galb1, 4(Fuca1, 3)GlcNAc | GM2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Lc3 | GD1bCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1cCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcb1, 3Gal | GM1asph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GT1cCer d20:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d20:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Galc d18:1/16:1（GalaCeramide） |